Accordingly, strategies to inhibit expression of these stimuli can aid in indirectly suppressing Arid5a expression and be posed as alternate treatment options for IL-6-dependent inflammatory and autoimmune diseases. This evidence concerns the gene ARID5A and autoimmune disease.